Novartis

KYMRIAH - Cost

Last Updated: April 1st, 2024

HCPCS:

Q2042

HCPCS Code Descriptor:

Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Medicare Payment Limit:

The KYMRIAH Medicare Payment Limit is $518240.68

Average Sale Price:

KYMRIAH ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The KYMRIAH Medicare Co-insurance percentage is 19.31%. KYMRIAH's Medicare Co-insurance amount is $100072.28 per HCPCS unit.

APC Code:

The Kymriah APC Code is: 9194

APC Payment Limit:

The APC Payment Limit for KYMRIAH is available. Login to view.

Kymriah Cost Information:

KYMRIAH, became effective on January 1, 2019, and is aligned to HCPCS Q2042. From its inception, prices remained unchanged until 2022. At that time, prices began to increase by an estimated 5% each year. Towards the end of 2023, ASP experienced a substantial increase to rise above WAC.

ACCESS PRICING AND MORE BY REGISTERING

Kymriah’s wholesale acquisition cost (WAC) information was last updated on:
April 1, 2024
Kymriah’s average wholesale price (AWP) information was last updated on:
April 1, 2024

Kymriah Cost Graph: